Luminee

Luminee is an AI ecosystem of virtual assistants developed by Anju Software for clinical trial build automation. It ingests trial protocols and automatically creates trial-ready databases, edit checks, and validation artifacts, targeting a reduction in study build time of up to 90%. The platform is designed for sponsors, CROs, and the broader clinical trial ecosystem, supporting roles including study builders, data managers, ClinOps leaders, executives, CRAs, and site coordinators.

Traditional clinical trial database builds average 60–75 days and can require months of programmer time, with research from Tufts CSDD estimating delays cost sponsors between $1 million and $8 million per day. Luminee addresses this by automating protocol ingestion, database construction, and validation artifact generation to accelerate trial startup and reduce operational costs.

Core Capabilities

• Fast Protocol Ingestion: Reads protocol documents in any format and automatically creates study objects aligned with CDASH/SDTM standards and existing organizational libraries.
• NLP Edit Checks: Uses natural language processing to automatically generate edit check rules, supporting data quality from the start of a study.
• Automated Validation: Produces test cases, test patient data, and validation artifacts to support user acceptance testing (UAT) and audit readiness.
• Protocol Summarizer: Transforms complex trial protocols into site-focused summaries that highlight operational and patient impact insights, intended to reduce review burden and improve alignment at clinical sites. This feature is available at no cost via the Luminee Hub.
• Scalable Productivity: Supports teams in managing multiple trials in parallel, reducing resource bottlenecks.

How Luminee Works

1. Upload Protocol: Luminee ingests any protocol document submitted by the user.
2. AI Builds Database: Study objects and edit checks are created automatically based on the ingested protocol.
3. Go Live Faster: The team reviews the generated build while Luminee simultaneously auto-generates test cases, test patient data, and validation artifacts.

Data Sovereignty and Security

• Anju Software does not monetize or repurpose customer data. User data is not used to train external AI models.
• Full data sovereignty is maintained by design, meaning all data processed through Luminee remains exclusively owned by the customer.
• This approach is positioned as a distinguishing factor from other AI vendors in the clinical trial space.

Reported Outcomes

• Reduction in study build time of up to 90% compared to traditional methods.
• Reduction in data queries.
• Productivity gains enabling teams to handle more trials with existing resources.
• Typical Phase III builds reduced from months to days.

Luminee is offered by Anju Software as a purpose-built clinical trial automation tool, distinct from general-purpose AI platforms. The Protocol Summarizer component is available for self sign-up at no cost through the Luminee Hub, while the full platform is available via a demo request.